Inhibition of cardiac myocyte division in c-myc transgenic mice

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 7, 1997, Pages 1895-1902

  Machida, Noboru ^a,b   Brissie, Nancy ^a   Sreenan, Catherine ^a   Bishop, Sanford P ^a  

^a University of Alabama at Birmingham   (United States)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Bromodeoxyuridine; c myc; Myocardial growth; Myocyte hyperplasia; Neonatal; Protooncogene; Transgenic mouse

Indexed keywords

BROXURIDINE; MYC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMEGALY; CELL CYCLE S PHASE; CELL DIVISION; CELL GROWTH; CELL HYPERPLASIA; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; EMBRYO; FETUS; FETUS DEVELOPMENT; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE SEPTUM; IMAGE ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0031194731     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0427     Document Type: Article

References (27)

1. BISHOP SP, 1990. The myocardial cell: normal growth, cardiac hypertrophy and response to injury. Toxicol Pathol 18: 438-453.
2. CHARRON J, MALYNN BA, FISHER P, STEWART V, JEANNOTTE L, GOFF SP, ROBERTSON EJ, ALT FW, 1992. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev 6: 2248-2257.
3. CLUBB FJ JR, BISHOP SP, 1984. Formation of binucleated myocardial cells in the neonatal rat: an index for growth hypertrophy. Lab Invest 50: 571-577.
4. CLUBB FJ JR, PENNEY DG, BAYLERIAN MS, BISHOP SP, 1986. Cardiomegaly due to myocyte hyperplasia in perinatal rats exposed to 200 ppm carbon monoxide. J Mol Cell Cardiol 18: 477-486.
5. CLUBB FJ JR, BELL PD, KRISEMAN JD, BISHOP SP, 1987. Myocardial cell growth and blood pressure development in neonatal spontaneously hypertensive rats. Lab Invest 56: 189-197.
6. ENGELMANN GL, BOEHM KD, BIRCHENALL-ROBERTS MC, RUSCETTI FW, 1992. Transforming growth factor-beta 1 in heart development. Mech Dev 38: 85-97.
7. GALAKTIONOV K, CHEN X, BEACH D, 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511-517.
8. GERDES AM, KRISEMAN J, BISHOP SP, 1983. Changes in myocardial cell size and number during the development and reversal of hyperthyroidism in neonatal rats. Lab Invest 48: 598-602.
9. GRIEP AE, WESTPHAL H, 1988. Antisense myc sequences induce differentiation of F9 cells. Proc Natl Acad Sci USA 85: 6806-6810.
10. HOLT JT, REDNER RL, NIENHUIS AW, 1988. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol 8: 963-973.
11. JACKSON T, ALLARD MF, SREENAN CM, DOSS LK, BISHOP SP, SWAIN JL, 1990. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol 10: 3709-3716.
12. JACKSON T, ALLARD MF, SREENAN CM, DOSS LK, BISHOP SP, SWAIN JL, 1991. Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development. Mol Cell Biochem 104: 15-19.
13. KOMURO I, KURABAYASHI M, TAKAKU F, YAZAKI Y, 1988. Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res 62: 1075-1079.
14. LIBBY P, 1984. Long-term culture of contractile mammalian heart cells in a defined serum-free medium that limits non-muscle cell proliferation. J Mol Cell Cardiol 16: 803-811.
15. MARCU KB, 1987. Regulation of expression of the c-myc proto-oncogene. [Review]. Bioessays 6: 28-32.
16. MOENS CB, STANTON BR, PARADA LF, ROSSANT J, 1993. Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. Development 119: 485-499.
17. NEFFGEN JF, KORECKY B, 1972. Cellular hyperplasia and hypertrophy in cardiomegalies induced by anemia in young and adult rats. Circ Res 30: 104-113.
18. PETERSEN RO, BASERGA R, 1965. Nucleic acid and protein synthesis in cardiac muscle of growing and adult mice. Exp Cell Res 40: 340-352.
19. PIPER HM, JACOBSON SL, SCHWARTZ P, 1988. Determinants of cardiomyocyte development in long-term primary culture. J Mol Cell Cardiol 20: 825-835.
20. RAMSAY GM, MOSCOVICI G, MOSCOVICI C, BISHOP JM, 1990. Neoplastic transformation and tumorigenesis by the human protooncogene MYC. Proc Natl Acad Sci USA 87: 2102-2106.
21. RUMYANTSEV PP, 1977. Interrelations of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int Rev Cytol 51: 187-273.
22. SASAKI R, MORISHITA T, ICHIKAWA S, YAMAGATA S, 1970. Autoradiographic studies and mitosis of heart muscle cells in experimental cardiac hypertrophy. Tohoku J Exp Med 102: 159-167.
23. SAWAI S, SHIMONO A, WAKAMATSU Y, PALMES C, HANAOKA K, KONDOH H, 1993. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 117: 1445-1455.
24. SCHNEIDER MD, PAYNE PA, UENO H, PERRYMAN MB, ROBERTS R, 1986. Dissociated expression of c-myc and a fos-related competence gene during cardiac myogenesis. Mol Cell Biol 6: 4140-4143.
25. STANTON BR, PERKINS AS, TESSAROLLO L, SASSOON DA, PARADA LF, 1992. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 6: 2235-2247.
26. SWAIN JL, STEWART TA, LEDER P, 1987. Parental legacy determines methylation and expression of an autosomal transgene: a molecular mechanism for parental imprinting. Cell 50: 719-727.
27. WICKSTROM EL, BACON TA, GONZALEZ A, FREEMAN DL, LYMAN GH, WICKSTROM E, 1988. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci USA 85: 1028-1032.